| Q89634052 | A Review of Small Molecule Inhibitors and Functional Probes of Human Cathepsin L |
| Q73827911 | A novel procaspase-3 activating cascade in liver lysosomes, and lack of the cascade in hepatoma cells |
| Q55474273 | Affinity-Enhanced Luminescent Re(I)- and Ru(II)-Based Inhibitors of the Cysteine Protease Cathepsin L. |
| Q35870565 | An Active 32-kDa Cathepsin L Is Secreted Directly from HT 1080 Fibrosarcoma Cells and Not via Lysosomal Exocytosis |
| Q42380738 | Caging the uncageable: using metal complex release for photochemical control over irreversible inhibition |
| Q28543230 | Cathepsin B in antigen-presenting cells controls mediators of the Th1 immune response during Leishmania major infection |
| Q33705115 | Cathepsin L Inhibition Prevents Murine Autoimmune Diabetes via Suppression of CD8+ T Cell Activity |
| Q34654358 | Cathepsin L activity controls adipogenesis and glucose tolerance |
| Q39617432 | Cathepsin L is required for ecotropic murine leukemia virus infection in NIH3T3 cells |
| Q28591251 | Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity |
| Q41845464 | Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft. |
| Q27622021 | Crystal structure of cathepsin X: a flip-flop of the ring of His23 allows carboxy-monopeptidase and carboxy-dipeptidase activity of the protease |
| Q26860406 | Cysteine cathepsins: from structure, function and regulation to new frontiers |
| Q35098737 | Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases |
| Q39819247 | Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis |
| Q37403124 | Impaired autophagic flux mediates acinar cell vacuole formation and trypsinogen activation in rodent models of acute pancreatitis |
| Q87421342 | Inhibition of cysteine cathepsin B and L activation in astrocytes contributes to neuroprotection against cerebral ischemia via blocking the tBid-mitochondrial apoptotic signaling pathway |
| Q33327656 | Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L |
| Q26749121 | Lysosomal cathepsins and their regulation in aging and neurodegeneration |
| Q44068250 | Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer |
| Q37015016 | Major role of cathepsin L for producing the peptide hormones ACTH, beta-endorphin, and alpha-MSH, illustrated by protease gene knockout and expression |
| Q38799069 | Microbial inhibitors of cysteine proteases. |
| Q41889166 | Molecular docking of cathepsin L inhibitors in the binding site of papain |
| Q44468632 | New cysteine protease inhibitors in physiological secretory fluids and their medical significance |
| Q28176872 | New functions of lactoferrin and beta-casein in mammalian milk as cysteine protease inhibitors |
| Q28198107 | Novel procaspase-3 activating cascade mediated by lysoapoptases and its biological significances in apoptosis |
| Q36646524 | Processing of human cathepsin D is independent of its catalytic function and auto-activation: involvement of cathepsins L and B. |
| Q28612038 | Proteolysis and antigen presentation by MHC class II molecules |
| Q50091548 | Ru(ii) polypyridyl complexes as photocages for bioactive compounds containing nitriles and aromatic heterocycles |
| Q98389656 | SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells |
| Q30835088 | Solid-phase library synthesis, screening, and selection of tight-binding reduced peptide bond inhibitors of a recombinant Leishmania mexicana cysteine protease B. |
| Q40717671 | Structure-based development of cathepsin L inhibitors and therapeutic applications for prevention of cancer metastasis and cancer-induced osteoporosis. |
| Q34598268 | Structure-based development of specific inhibitors for individual cathepsins and their medical applications |
| Q36775345 | Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L. |
| Q34157437 | The genesis of high-throughput structure-based drug discovery using protein crystallography |
| Q36372829 | The protease cathepsin L regulates Th17 cell differentiation |